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Abstract
As a result of variable expression of biochemical characters, misidentiﬁcation by conventional phenotypic means often occurs with clini-
cal isolates belonging to Staphylococcus species. Therefore, we evaluated the use of matrix-assisted laser desorption ionization-time-of-
ﬂight mass spectrometry (MALDI-TOF MS) for the identiﬁcation of 450 blood isolates of the most relevant staphylococcal species, using
sequence analysis of the rpoB gene as the reference method. A correct species identiﬁcation by MALDI-TOF was obtained in 99.3%
(447/450), with only three isolates being misidentiﬁed. In addition, MALDI-TOF correctly identiﬁed all the staphylococcal subspecies
studied, including Staphylococcus capitis subsp. capitis and subsp. urealyticus, Staphylococcus cohnii subsp. urealyticus, Staphylococcus hominis
subsp. novobiosepticus and subsp. hominis, Staphylococcus saprophyticus subsp. saprophyticus, Staphylococcus schleiferi subsp. schleiferi and
Staphylococcus sciuri subsp. sciuri. Thus, MALDI-TOF MS-based species identiﬁcation of staphylococci can be routinely achieved without
any substantial costs for consumables or the time needed for labour-intensive DNA sequence analysis.
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Introduction
Among the over 40 well-recognized species and subspecies
of staphylococci [1,2], Staphylococcus aureus is the leading
human pathogen not only in hospitals, but also in communi-
ties, even though other staphylococcal species (e.g. Staphylo-
coccus epidermidis, Staphylococcus hominis, Staphylococcus
capitis, Staphylococcus haemolyticus, Staphylococcus warneri and
Staphylococcus lugdunensis) are increasingly insolated from
infections in immunocompromised patients, patients using
catheters [3] and native valve endocarditis [4]. Therefore,
failure to unequivocally distinguish between staphylococcal
species can have far-reaching clinical and epidemiological
repercussions [5]. Nevertheless, the precise identiﬁcation of
these bacteria at the species level remains difﬁcult, with
some strains being misidentiﬁed with closely-related species,
especially when conventional phenotypic methods are
employed. DNA sequence analysis using different nucleic acid
targets is an alternative technique for the accurate identiﬁca-
tion of Staphylococcus species [6], although it should be
emphasized that additional/supplementary methods might be
necessary for those species that cannot be delineated by
sequence comparison of a single gene (i.e. 16S rDNA) [7].
Matrix-assisted laser desorption ionization-time-of ﬂight
mass spectrometry (MALDI-TOF MS) has emerged as a new
technology for the rapid analysis of protein components of
bacterial cells [8]. Extensive high-quality databases of type
and reference strains are available as integrated parts of soft-
ware such as BioTyper (Bruker Daltonik GmbH, Leipzig,
Germany) or Waters MicrobeLynx (Waters Corp., Milford,
MA, USA) [8], which claim to allow accurate, reproducible,
and cost-effective species identiﬁcation for the major groups
of pathogenic bacteria [9]. Carbonelle et al. [10] demon-
strated that sets of selected peaks from each of 23 reference
strains, corresponding to the clinically relevant species and
subspecies of Micrococcaceae, could be used as a database for
the rapid identiﬁcation of clinical coagulase-negative staphylo-
cocci (CoNS) isolates. Using this database, Carbonelle’s
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group achieved a correct species identiﬁcation in 97.4% of
their CoNS isolates with MALDI-TOF MS analysis [11].
By contrast, 86 (22.3%) of 385 CoNS isolates, as well as iso-
lates from others of >100 bacterial species analysed by Seng
et al. [9], were identiﬁed only at the genus level using the
Bruker BioTyper database. Because precision in MALDI-TOF
MS identiﬁcation was signiﬁcantly correlated with the fact
that the database for those species included ‡10 reference
spectra, the authors claimed that a complete and representa-
tive database was a critical requirement for the accurate
identiﬁcation of isolates by MALDI-TOF MS.
The present study aimed to re-evaluate the identiﬁcation
performance of the Bruker BioTyper database by testing a
large number of blind-coded clinical staphylococcal isolates
representing the species routinely identiﬁed from blood-
stream infections in the diagnostic microbiology laboratory.
Because rpoB gene sequence has been shown to differentiate
bacterial species not distinguishable by 16S rRNA gene
sequence [12], partial rpoB gene sequencing was used as the
reference method in the present study.
Materials and methods
Bacterial isolates and molecular identiﬁcation
We studied a collection of 450 nonrepetitive staphylococcal
isolates (Table 1) recovered from blood specimens received
by our Institution from January 2007 to September 2009.
Most of the CoNS isolates were from cases of bacteraemia
as previously deﬁned [13].
PCR ampliﬁcation and sequencing of the partial rpoB gene
from the study isolates were performed using primers 2491F
and 3241R [14] and, when appropriate, additional primers
speciﬁcally designed to identify all staphylococcal subspecies
[15]. An isolate was correctly identiﬁed when its partial rpoB
gene sequence yielded ‡97% sequence similarity with the
closest bacterial species sequence in GenBank.
MALDI-TOF MS
For MALDI-TOF MS analysis, cells from a single colony of
fresh overnight culture were used for each isolate to prepare
samples according to the microorganism proﬁling ethanol/
acid formic extraction procedure, as recommended by the
manufacturer. After centrifugation at maximum speed for
2 min, 1 lL of each supernatant containing the bacterial
extract was allowed to dry after overlaying it with 2 lL of a
chemical matrix (saturated solution of a-cyano-4-hydroxy-
cinnamic acid in 50% acetonitrile/2.5% triﬂuoroacetic acid)
on a polished steel MALDI target plate. The samples were
then processed in the microﬂex LT (Bruker Daltonik GmbH)
mass spectrometer equipped with a 20-Hz nitrogen laser.
The spectra were recorded in the positive linear mode as
described elsewhere [10].
Data analysis
To identify microorganisms, the raw spectra obtained for
each isolate were imported into BioTyper software, version
2.0 (Bruker Daltonik GmbH), and analysed without any user
intervention, using default parameter settings, by the
standard pattern matching algorithm against the spectra of
TABLE 1. Identiﬁcation results
obtained with the matrix-assisted
laser desorption ionization-time-of-
ﬂight mass spectrometry system
for 450 Staphylococcus isolates
Species (number tested)
Number (%) of isolates with
indicated result
Identiﬁed Misidentiﬁcation
Staphylococcus aureus subsp. aureus (115) 115 0
Staphylococcus arlettae (1) 1 0
Staphylococcus capitis subsp. capitis (8) 8 0
Staphylococcus capitis subsp. urealyticus (4) 4 0
Staphylococcus caprae (1) 1 0
Staphylococcus cohnii subsp. urealyticus (6) 6 0
Staphylococcus epidermidis (199) 198 1a
Staphylococcus haemolyticus (36) 36 0
Staphylococcus hominis subsp. novobiosepticus (32) 32 0
Staphylococcus hominis subsp. hominis (17) 17 0
Staphylococcus lugdunensis (8) 8 0
Staphylococcus pettenkoferi (1) 0 1b
Staphylococcus saprophyticus subsp. saprophyticus (1) 1 0
Staphylococcus schleiferi subsp. schleiferi (1) 1 0
Staphylococcus sciuri subsp. sciuri (2) 2 0
Staphylococcus simulans (10) 10 0
Staphylococcus warneri (7) 6 1c
Staphylococcus xylosus (1) 1 0
Total 447 (99.3) 3 (0.7)
aMisidentiﬁed as S. hominis subsp. novobiosepticus.
bMisidentiﬁed as S. haemolyticus.
cMisidentiﬁed as S. simulans.
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3294 species in the Biotyper database, version 3.0 (updated
October 2008). The reference database consisted of 126
main spectra encompassing 46 Staphylococcus species and
subspecies, as depicted in the dendrogram generated from
the corresponding spectra (Fig. 1). The results of the pattern
matching process were expressed as log(score) values in the
range 0–3, using values of ‡2.0 for identiﬁcation to the spe-
cies level and values of between <2 and ‡1.7 for identiﬁca-
tion to the genus level. The highest log(score) of a match
against the database was used for species identiﬁcation.
Results
In a typical analysis of staphylococcal isolates by MALDI-TOF
MS, 10–20 prominent ion peaks were noted in the spectra
from the region in the range 2 000–11 000 Da, with the
highest-intensity peaks being consistently in the range 3000–
10 000 Da. On this basis, the log(score) values obtained by
MALDI-TOF MS correctly identiﬁed all but three staphylo-
coccal isolates at the species level [log(score), ‡2.0], as sub-
sequently conﬁrmed by the rpoB gene sequence-based
molecular analysis. S. aureus isolates were 100% correctly
identiﬁed. A correct identiﬁcation was obtained in 99.1%
(332/335) of the CoNS isolates. Among the three species
that most frequently cause disease in humans or are isolated
most frequently from human samples, S. epidermidis
(n = 199), S. hominis (n = 49) and S. haemolyticus (n = 36),
MALDI-TOF MS gave a correct identiﬁcation in 99.6% (283/
284), with one S. epidermidis isolate being misidentiﬁed as
S. hominis (subsp. novobiosepticus) [log(score) = 2.062]. Of
two other isolates not correctly identiﬁed, one was identi-
ﬁed as Staphylococcus simulans) by MALDI-TOF MS [log(-
score) = 2.084] and as S. warneri by rpoB sequencing, and,
interestingly, the other isolate was identiﬁed as S. haemolyti-
cus by MALDI-TOF MS [log(score) = 2.252] and as Staphylo-
coccus pettenkoferi by rpoB sequencing (Table 1).
Discussion
As recently stated by Dupont et al. [11], misidentiﬁcation
often results from the heterogeneous behaviour of the
CoNS population obtained from clinical specimens, particu-
larly when conventional phenotypic identiﬁcation means are
employed. In two different studies published in 2008, the use
of current automated biochemical tests [the Phoenix and
Vitek 2 (bioMe´rieux, Marcy l’Etoile, France) (Becton-Dickinson,
MSP dendrogram
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Staphylococcus pulvereri DSM 9931
Staphylococcus vitulinus DSM 15615
Staphylococcus fleurettii DSM 13212
Staphylococcus sciuri ssp rodentium DSM 16827
Staphylococcus sciuri ssp carnaticus DSM 15613
Staphylococcus sciuri ssp sciuri DSM 20345T
Staphylococcus lentus DSM 20352
Staphylococcus arlettae DSM 20672
Staphylococcus equorum ssp equorum DSM 20674
Staphylococcus lugdunensis 20659_1 CHB
Staphylococcus cohnii ssp cohnii DSM 20260
Staphylococcus cohnii ssp urealyticum DSM 6718
Staphylococcus xylosus DSM 20266
Staphylococcus saprophyticus ssp saprophyticus CCM 235
Staphylococcus kloosii DSM 20676T
Staphylococcus nepalensis DSM 15150_DSM
Staphylococcus succinus ssp casei DSM 15096
Staphylococcus succinus ssp succinus DSM 14617T
Staphylococcus pasteuri DSM 10656
Staphylococcus warneri CCM 2604 CCM
Staphylococcus simulans CCM 2724 CCM
Staphylococcus hominis ssp hominis DSM 20328_DSM
Staphylococcus hominis ssp novobiosepticus DSM 15614
Staphylococcus aureus ssp anaerobius DSM 20714_DSM
Staphylococcus aureus ssp aureus DSM 11822
Staphylococcus simiae DSM 17636
Staphylococcus capitis ssp capitis DSM 20325
Staphylococcus capitis ssp urealyticus DSM 6717
Staphylococcus caprae DSM 20608_DSM
Staphylococcus epidermidis 10547 CHB
Staphylococcus auricularis DSM 20609
Staphylococcus chromogenes DSM 20454
Staphylococcus hyicus DSM 17421_DSM
Staphylococcus muscae DSM 7068
Staphylococcus delphini DSM 20771
Staphylococcus intermedius 08_STAINT MVO
Staphylococcus felis DSM 7377
Staphylococcus lutrae DSM 10244
Staphylococcus schleiferi ssp coagulans DSM 6628 DSM
Staphylococcus schleiferi ssp schleiferi DSM 4807
Staphylococcus carnosus ssp carnosus DSM 20501
Staphylococcus condimenti DSM 11674
Staphylococcus piscifermentans DSM 7373
Staphylococcus carnosus ssp utilis DSM 11676
Staphylococcus haemolyticus 10024 CHB
Staphylococcus lactis DSM 20033
FIG. 1. Score oriented dendrogram showing the spectral similarities of staphylococcal type strains (n = 46), as obtained by Microﬂex LT (Bruker
Daltonik GmbH).
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Becton-Dickinson Biosciences, Franklin Lakes, NJ, USA) sys-
tems] gave correct identiﬁcation rates for CoNS of only
90.5% and 87.5%, respectively [16,17]. Thus, although various
degrees of accuracy can be achieved with different available
biochemical-based commercial kits and automated systems,
phenotypic characterization remains equivocal, even for clini-
cal isolates belonging to the S. aureus species. Conversely,
but in agreement with our results, Rajakaruna et al. [18]
showed that all of 134 clinical isolates presumptively identi-
ﬁed as S. aureus, were identiﬁed correctly with MALDI-TOF
MS using the MicrobeLynx software.
Despite a moderate degree of species representativity in
our CoNS isolate collection, the overall percentage of cor-
rect identiﬁcation results using MALDI-TOF MS was superior
to that of previous studies [9,11]. We obtained a correct
identiﬁcation in 84.7% of S. epidermidis, S. hominis and S. hae-
molyticus isolates compared to the 42% achieved by Dupont
et al. [11]. We had a 100% correct identiﬁcation for
the S. haemolyticus isolates compared to the 85.8% of
Dupont et al.
In the present study, MALDI-TOF correctly identiﬁed
99.1% of CoNS isolates compared to the 77.7% correct identi-
ﬁcations reported by Seng et al. [9]. This may be related to
differences in the species distributions in these two studies. In
our study, three CoNS isolates were misidentiﬁed; for all the
three isolates, rpoB gene sequence similarities to the reference
identity were close to 100% (99.5–99.7%) and, in this method,
a similarity threshold of ‡94% is said to be reliable for correct
species designation of clinical staphylococcal isolates [15].
It is known that the success of species matching is depend-
ing upon the number of strain entries within the database for
a given species, but it is also true that overlapping signal ions
increase with the number of the strains registered in the
database, making it difﬁcult to identify species- or subspecies-
speciﬁc markers in the spectra [8]. The results obtained
clearly show that accurate MALDI-TOF MS identiﬁcation was
possible for isolates belonging to species with less than ﬁve
reference spectra in the database, such as Staphylococcus arlet-
tae, Staphylococcus caprae, S. schleiferi, S. sciuri and S. warneri.
As already discussed [19], marked differences in antimi-
crobial resistance patterns in some staphylococcal species
and subspecies make their differentiation essential in clinical
practice. One remarkable ﬁnding of the present study was
the good performance of MALDI-TOF in identifying all the
CoNS subspecies tested, including S. capitis subsp. capitis and
subsp. urealyticus, S. cohnii subsp. urealyticus, S. hominis subsp.
novobiosepticus and subsp. hominis, S. saprophyticus subsp. sap-
rophyticus, S. schleiferi subsp. schleiferi and S. sciuri subsp. sciuri
(Table 1). As an example, different peak proﬁles among the
subspecies of S. hominis and those of S. capitis could easily be
noted in their MS spectra (Fig. 2). S. pettenkoferi, a novel
CoNS species isolated from human clinical specimens [20],
in
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FIG. 2. Matrix-assisted laser desorption ionization-time-of-ﬂight mass spectrometry of (a) Staphylococcus hominis subsp. novobiosepticum, (b) Staph-
ylococcus hominis subsp. hominis, (c) Staphylococcus capitis subsp. capitis and (d) Staphylococcus capitis subsp. urealyticus, showing the differences
among the subspecies. The absolute intensities of the ions are shown on the y-axis, and the masses (Da) of the ions are shown on the x-axis.
The m/z value represents the mass to charge ratio.
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has very recently been reported as a cause of bloodstream
infection [21]. This species was not included in the Biotyper
database, although the introduction of the spectrum of our
isolate into the database allowed unequivocal identiﬁcation
(data not shown). However, this unique spectrum is not suf-
ﬁcient to conﬁrm the isolate identity [9] and additional
S. pettenkoferi spectra are needed to represent the actual
diversity of S. pettenkoferi proﬁles.
Despite the successful use of sodA and tuf genes as new
molecular targets [6], the results obtained in the present
study conﬁrm the well-known high discriminative power of
rpoB gene [14,15] for differentiating staphylococcal isolates
at the species and subspecies level. Nevertheless, when we
compared this molecular technique with MALDI-TOF MS in
terms of turnaround time (calculated as the minimum sam-
ple time required to produce an identiﬁcation result) and
cost–beneﬁt, we note that MS is quicker (10 min vs.
8 h) and, remarkably, more cost-effective, as a result of
inexpensive consumables and simple operating procedures
that do not require specialized laboratory technicians. This
conﬁrms the previous observations made with this tech-
nique [9,22,23].
In conclusion, we consider that MALDI-TOF MS technol-
ogy can be routinely used as a rapid method for reliable spe-
cies identiﬁcation of staphylococcal isolates. This is an
attractive method for clinical microbiologists because it
appears to be superior to phenotypic methods and is more
cost-effective than labour-intensive DNA sequence analysis.
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